Treatment Patterns and Outcomes of Stage III Non-Small Cell Lung Cancer (NSCLC): Real World Evidence of How our Patients Fare

被引：1
作者：
Yusuf, D. [1 ]
Walton, R. [2 ]
Hurry, M. [2 ]
Cheung, W. [3 ,4 ]
机构：
[1] Cross Canc Inst, Dept Med Oncol, Edmonton, AB, Canada
[2] Astrazeneca Canada, Mississauga, ON, Canada
[3] Univ Calgary, Med, Calgary, AB, Canada
[4] Alberta Hlth Serv, Calgary, AB, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
outcomes; Treatments; NSCLC;
D O I：
10.1016/j.jtho.2018.08.967
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.15-34
引用
收藏
页码：S626 / S626
页数：1
相关论文
共 50 条
  • [21] Real-World Insights into the Impact of Durvalumab on Stage III Unresectable Non-Small Cell Lung Cancer-A Narrative Review
    Facheris, Giorgio
    Cossali, Gianluca
    Imbrescia, Jessica
    La Mattina, Salvatore
    Mataj, Eneida
    Meli, Nicole
    Volpi, Giulia
    Triggiani, Luca
    Guerini, Andrea Emanuele
    Levi, Guido
    Grisanti, Salvatore
    di Monale e Bastia, Michela Buglione
    Borghetti, Paolo
    CANCERS, 2025, 17 (05)
  • [22] Surgery for Elderly Patients with Stage III Non-Small-Cell Lung Cancer (NSCLC)?
    Passlick, B.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S91 - S92
  • [23] Systemic therapy treatment patterns in patients with advanced non-small cell lung cancer (NSCLC): PIvOTAL study
    de Castro, J.
    Tagliaferri, P.
    de Lima, V. C. C.
    Ng, S.
    Thomas, M.
    Arunachalam, A.
    Cao, X.
    Kothari, S.
    Burke, T.
    Myeong, H.
    Grattan, A.
    Lee, D. H.
    EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (06)
  • [24] Real-world treatment outcomes with brigatinib in patients with pretreated ALK plus metastatic non-small cell lung cancer
    Popat, Sanjay
    Brustugun, Odd Terje
    Cadranel, Jacques
    Felip, Enriqueta
    Garassino, Marina Chiara
    Griesinger, Frank
    Helland, Aslaug
    Hochmair, Maximilian
    Perol, Maurice
    Bent-Ennakhil, Nawal
    Kruhl, Christian
    Novello, Silvia
    LUNG CANCER, 2021, 157 : 9 - 16
  • [25] Treatment patterns and outcomes in early-stage ALK-rearranged non-small cell lung cancer
    Schmid, Sabine
    Garcia, Miguel
    Cheng, Sierra
    Zhan, Luna
    Chotai, Simren
    Balaratnam, Karmugi
    Khan, Khaleeq
    Patel, Devalben
    Brown, M. Catherine
    Sachdeva, Robin
    Xu, Wei
    Shepherd, Frances A.
    Sacher, Adrian
    Leighl, Natasha B.
    Bradbury, Penelope
    Moriarty, Patrick
    Kuruvilla, M. Sara
    Liu, Geoffrey
    LUNG CANCER, 2022, 166 : 58 - 62
  • [26] Real-World Neoadjuvant Treatment Patterns and Outcomes in Resected Non-Small-Cell Lung Cancer
    Donington, Jessica
    Hu, Xiaohan
    Zhang, Su
    Song, Yan
    Arunachalam, Ashwini
    Chirovsky, Diana
    Gao, Chi
    Lerner, Ari
    Jiang, Anya
    Signorovitch, James
    Samkari, Ayman
    CLINICAL LUNG CANCER, 2024, 25 (05) : 440 - 448
  • [27] Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives
    Lazzari, Chiara
    Spagnolo, Calogera Claudia
    Ciappina, Giuliana
    Di Pietro, Martina
    Squeri, Andrea
    Passalacqua, Maria Ilenia
    Marchesi, Silvia
    Gregorc, Vanesa
    Santarpia, Mariacarmela
    CURRENT ONCOLOGY, 2023, 30 (04) : 3684 - 3696
  • [28] Accuracy of Clinical Stage in Resectable Non-small Cell Lung Cancer (NSCLC)
    Gwon, H. R.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S520 - S521
  • [29] New perspectives in the treatment of non-small cell lung cancer (NSCLC)
    Brockmoeller, Juergen
    Junker, Klaus
    Multhoff, Gabriele
    ONKOLOGIE, 2006, 29 : 25 - 28
  • [30] Clinical Characteristics and Treatment Patterns of NSCLC Stage III Patients from Real World
    Kathmann, L.
    Roeper, J.
    Wedeken, K.
    Willborn, K.
    Griesinger, F.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S284 - S284
12345